Oryzon Genomics is a clinical‐stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases.
ProKidney Corp.
1 follower
Xilio Therapeutics
2 followers
Women In Bio - Engage. Educate. Empower.
1 follower
Truveta
5 followers
Galvanize Therapeutics, Inc.
2 followers
Adimab
1 follower
Clinion
1 follower
Microbial Discovery Group
1 follower
Zinzino
2 followers
ProcDNA
1 follower
APHL
1 follower
Rosemont Pharmaceuticals
2 followers